Funding source also tended to be predictive (borderline significant), with commercial funding or unstated funding increasing the hazard for study discontinuation as compared to non-commercial funding.
← all excerpts
A multi-state model analysis of the time from ethical approval to publication of clinical research studies.
1
—
—